Key Developments Lifting These Shares on Upside - IMU, ALD, WDS

Imugene Limited (ASX: IMU), a clinical stage immunooncology company, has achieved a significant milestone as it has been granted a Notice of Allowance from the US Patent and Trademark Office (USPTO) for its patent application protecting oncolytic virotherapy CF33. The patent provides Imugene with exclusive rights for the composition and uses of the chimeric poxvirus until 2037. CF33, developed by Professor Yuman Fong, is an oncolytic virus designed to selectively target and destroy tumor cells while stimulating the immune system against cancer. This patent allowance is particularly important considering the US healthcare market's significance.

Imugene Limited closed at a last price of $0.102, reflecting a positive change of $0.009 (10.215%) for the day.

Ampol Limited (ASX: ALD) has provided an update on its trading conditions and financial performance for the first half of the 2023 financial year. The company's unaudited RCOP EBIT is approximately $575 million, with RCOP EBITDA around $800 million. Strong earnings growth was observed in non-refining divisions such as Fuels and Infrastructure and Convenience Retail, attributed to incremental margin management and improved margins. However, the performance of the Lytton refinery was impacted by lower Singapore product cracks, higher operating expenses, and losses related to the storage and export of intermediate products. Nonetheless, the refinery returned to normal operations by the end of May, resulting in an improved high-value production mix.

Ampol Limited closed at a last price of $31.120, reflecting a positive change of $1.280 (4.289%) for the day.

Woodside Petroleum (ASX: WDS), an Australian oil and gas company, has released its second-quarter report. Despite a 5% decrease in production due to planned maintenance activities, Woodside delivered quarterly production of 44.5 million barrels of oil equivalent (MMboe). The company reported revenue of $3,084 million, primarily influenced by lower realized prices and production. Woodside achieved a significant milestone with the first production at the Argos platform, marking progress in the Mad Dog Phase 2 project. The Scarborough and Pluto Train 2 projects also advanced well. Woodside made a final investment decision to develop the Trion resource offshore Mexico, pending regulatory approval, and for the Julimar-Brunello Phase 3 project, which will supply gas to the Wheatstone LNG facility. The company emphasized its commitment to safety and ongoing investigations following a tragic incident at the North Rankin Complex.

The last price of Woodside Energy Group Ltd was $36.010, reflecting a positive change of $0.459 (1.293%) for the day.

These key developments have positively impacted the shares of IMU, ALD, and WDS, signaling potential growth and investor confidence in their respective industries.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com